Real-world efficacy and toxicity of ipilimumab and nivolumab as first line treatment of metastatic renal cell carcinoma (mRCC) in a subpopulation of elderly and poor performance status patients.

Ana-Alicia Beltran-Bless, Christina M. Canil, Sunita Ghosh et al.|Journal of Clinical Oncology|2024

Cited by 2